GUTS
Fractyl Health, Inc. Common Stock
NASDAQ: GUTS · HEALTHCARE · BIOTECHNOLOGY
$0.64
+5.90% today
Updated 2026-04-30
Market cap
$103.61M
P/E ratio
—
P/S ratio
7,575.74x
EPS (TTM)
$-1.86
Dividend yield
—
52W range
$0 – $3
Volume
2.3M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D7.0
Quality
B+3.0
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-7.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$5.24
+721.96%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Debt/equity -19.57x — low leverage
Risks
- Altman Z -7.54 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-21.34M
- Revenue declining -57.10% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $120000.00 | $93000.00 | $0.00 | $3000.00 |
| Net income | $-46.45M | $-77.09M | $-68.69M | $-140.95M | $-43.73M |
| EPS | — | — | — | — | $-1.86 |
| Free cash flow | $-46.30M | $-43.18M | $-67.29M | $-90.89M | $-21.34M |
| Profit margin | — | -64,242.50% | -73,864.52% | — | — |
Peer comparison
Smart narrative
Fractyl Health, Inc. Common Stock trades at $0.64. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -7.54, it sits in the distress. TTM revenue stands at $3000.00.
Frequently asked questions
What is Fractyl Health, Inc. Common Stock's stock price?
Fractyl Health, Inc. Common Stock (GUTS) trades at $0.64.
Is Fractyl Health, Inc. Common Stock overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell).
What is the price target of Fractyl Health, Inc. Common Stock (GUTS)?
The analyst target price is $5.24, representing +722.0% upside from the current price of $0.64.
What is Fractyl Health, Inc. Common Stock's revenue?
TTM revenue is $3000.00.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-7.54 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio7,575.74x
ROE-744.00%
Beta1.19
50D MA$0.49
200D MA$1.20
Shares out0.16B
Float0.14B
Short ratio—
Avg volume2.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—